120 related articles for article (PubMed ID: 38417136)
21. Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR/β-catenin and MMP-14 for nitrogen homeostasis and liver cancer.
Elmetwalli A; Nageh A; Youssef AI; Youssef M; Ahmed MAE; Noreldin AE; El-Sewedy T
Med Oncol; 2023 Dec; 41(1):38. PubMed ID: 38157146
[TBL] [Abstract][Full Text] [Related]
22. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
[TBL] [Abstract][Full Text] [Related]
23. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
[TBL] [Abstract][Full Text] [Related]
24. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.
Liu H; Hu J; Wei R; Zhou L; Pan H; Zhu H; Huang M; Luo J; Xu W
J Exp Clin Cancer Res; 2018 Sep; 37(1):229. PubMed ID: 30249289
[TBL] [Abstract][Full Text] [Related]
25. β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation.
Lee JM; Yang J; Newell P; Singh S; Parwani A; Friedman SL; Nejak-Bowen KN; Monga SP
Cancer Lett; 2014 Feb; 343(1):90-7. PubMed ID: 24071572
[TBL] [Abstract][Full Text] [Related]
26. ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.
Yang W; Wang B; Yu Q; Liu T; Li T; Tian T; Jin A; Ding L; Chen W; Wang H; Xian J; Pan B; Zhou J; Fan J; Yang X; Guo W
Theranostics; 2022; 12(14):6189-6206. PubMed ID: 36168627
[No Abstract] [Full Text] [Related]
27. MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/β-catenin pathway in hepatocellular carcinoma.
Tuo H; Wang Y; Wang L; Yao B; Li Q; Wang C; Liu Z; Han S; Yin G; Tu K; Liu Q
Oncotarget; 2017 Sep; 8(39):65687-65698. PubMed ID: 29029464
[TBL] [Abstract][Full Text] [Related]
28. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
Jiang Y; Han Q; Zhao H; Zhang J
J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
[TBL] [Abstract][Full Text] [Related]
29. CDK7 activated beta-catenin/TCF signaling in hepatocellular carcinoma.
Duan J; He Y; Fu X; Deng Y; Zheng M; Lu D
Exp Cell Res; 2018 Sep; 370(2):461-467. PubMed ID: 29981747
[TBL] [Abstract][Full Text] [Related]
30. PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination.
Wen J; Xiong K; Aili A; Wang H; Zhu Y; Yu Z; Yao X; Jiang P; Xue L; Wang J
Theranostics; 2020; 10(12):5322-5340. PubMed ID: 32373215
[No Abstract] [Full Text] [Related]
31. USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through β-catenin stabilization.
Tang J; Long G; Xiao L; Zhou L
Cell Death Dis; 2023 Jun; 14(6):360. PubMed ID: 37311739
[TBL] [Abstract][Full Text] [Related]
32. TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.
Liang B; Zhou Y; Qian M; Xu M; Wang J; Zhang Y; Song X; Wang H; Lin S; Ren C; Monga SP; Wang B; Evert M; Chen Y; Chen X; Huang Z; Calvisi DF; Chen X
J Hepatol; 2021 Jul; 75(1):120-131. PubMed ID: 33577921
[TBL] [Abstract][Full Text] [Related]
33. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
34. Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation.
Liu M; Jiang K; Lin G; Liu P; Yan Y; Ye T; Yao G; Barr MP; Liang D; Wang Y; Gong P; Meng S; Piao H
J Exp Clin Cancer Res; 2018 Jul; 37(1):165. PubMed ID: 30041665
[TBL] [Abstract][Full Text] [Related]
35. LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC.
Cai Y; Lyu T; Li H; Liu C; Xie K; Xu L; Li W; Liu H; Zhu J; Lyu Y; Feng X; Lan T; Yang J; Wu H
J Exp Clin Cancer Res; 2022 Dec; 41(1):335. PubMed ID: 36471363
[TBL] [Abstract][Full Text] [Related]
36. Phosphatidylinositol 4-phosphate adaptor protein 2 accelerates the proliferation and invasion of hepatocellular carcinoma cells by enhancing Wnt/β-catenin signaling.
Fan W; Du F; Liu X
J Bioenerg Biomembr; 2020 Oct; 52(5):301-309. PubMed ID: 32914361
[TBL] [Abstract][Full Text] [Related]
37. UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells.
Long G; Wu Z; Wang D; Mi X; Hu K; Zhou L; Tang J
Free Radic Biol Med; 2024 Feb; 212():162-173. PubMed ID: 38092274
[TBL] [Abstract][Full Text] [Related]
38. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
[TBL] [Abstract][Full Text] [Related]
39. β-catenin-activated hepatocellular carcinomas are addicted to fatty acids.
Senni N; Savall M; Cabrerizo Granados D; Alves-Guerra MC; Sartor C; Lagoutte I; Gougelet A; Terris B; Gilgenkrantz H; Perret C; Colnot S; Bossard P
Gut; 2019 Feb; 68(2):322-334. PubMed ID: 29650531
[TBL] [Abstract][Full Text] [Related]
40. Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma.
Leung RWH; Lee TKW
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]